These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15556268)

  • 1. Probing the origins, diagnosis and treatment of amyloid diseases using antibodies.
    Dumoulin M; Dobson CM
    Biochimie; 2004; 86(9-10):589-600. PubMed ID: 15556268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for B lymphocytes in anti-infective prion therapies?
    Tayebi M; Bate C; Hawke S; Williams A
    Expert Rev Anti Infect Ther; 2007 Aug; 5(4):631-8. PubMed ID: 17678426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloidosis-associated kidney disease.
    Dember LM
    J Am Soc Nephrol; 2006 Dec; 17(12):3458-71. PubMed ID: 17093068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecules that target beta-amyloid.
    Stains CI; Mondal K; Ghosh I
    ChemMedChem; 2007 Dec; 2(12):1674-92. PubMed ID: 17952881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein chemistry. In the footsteps of alchemists.
    Dobson CM
    Science; 2004 May; 304(5675):1259-62. PubMed ID: 15166354
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein amyloidose misfolding: mechanisms, detection, and pathological implications.
    Jeyashekar NS; Sadana A; Vo-Dinh T
    Methods Mol Biol; 2005; 300():417-35. PubMed ID: 15657495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amyloidosis. A review].
    Thomsen JS; Horn T; Schlichting P
    Ugeskr Laeger; 1999 May; 161(21):3079-83. PubMed ID: 10377850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The workings of the amyloid diseases.
    Bellotti V; Nuvolone M; Giorgetti S; Obici L; Palladini G; Russo P; Lavatelli F; Perfetti V; Merlini G
    Ann Med; 2007; 39(3):200-7. PubMed ID: 17457717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid and amyloidosis.
    Cohen AS; Jones LA
    Curr Opin Rheumatol; 1992 Feb; 4(1):94-105. PubMed ID: 1543671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid in neurosurgical and neurological practice.
    Samandouras G; Teddy PJ; Cadoux-Hudson T; Ansorge O
    J Clin Neurosci; 2006 Feb; 13(2):159-67. PubMed ID: 16403633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The formation of Escherichia coli curli amyloid fibrils is mediated by prion-like peptide repeats.
    Cherny I; Rockah L; Levy-Nissenbaum O; Gophna U; Ron EZ; Gazit E
    J Mol Biol; 2005 Sep; 352(2):245-52. PubMed ID: 16083908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy.
    Margittai M; Langen R
    Q Rev Biophys; 2008; 41(3-4):265-97. PubMed ID: 19079806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis.
    Saito S; Ando Y; Nakamura M; Ueda M; Kim J; Ishima Y; Akaike T; Otagiri M
    Biochemistry; 2005 Aug; 44(33):11122-9. PubMed ID: 16101296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposition diseases and 3D domain swapping.
    Bennett MJ; Sawaya MR; Eisenberg D
    Structure; 2006 May; 14(5):811-24. PubMed ID: 16698543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
    Huang L; Liu X; Cheng B; Huang K
    Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical identification of amyloid, using an anti-human serum amyloid P component (SAP) antibody, is possible in ruminants but not in dogs and cats.
    Hartig W; Leifsson PS; Nielsen OL
    J Vet Med A Physiol Pathol Clin Med; 2005 Nov; 52(9):447-53. PubMed ID: 16268955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects on human amyloid forms and their fibril polypeptides.
    Westermark P
    FEBS J; 2005 Dec; 272(23):5942-9. PubMed ID: 16302959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
    Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
    J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.